Dec 2, 2025 · Tirzepatide (Zepbound) is a once-weekly weight loss injection. Clinical trials showed a 50-lb weight loss over 72 weeks. Learn about dosing, side effects, warnings, and who is …

Dec 1, 2025 · Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide injection is also used to help …

This site provides information about Mounjaro ® (tirzepatide) and Zepbound ® (tirzepatide), our prescription-only, FDA-approved medicines containing tirzepatide.

Mounjaro (tirzepatide) helps manage blood sugar in people with Type 2 diabetes. It also helps with weight loss. It’s an injection you take once every seven days.

Tirzepatide injection also slows the emptying of the stomach and may decrease appetite and cause weight loss. Over time, people who have diabetes and high blood sugar can develop …

Tirzepatide is a long-acting GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist that increases insulin sensitivity and secretion, …

5 days ago · Tirzepatide, synthetic antidiabetic drug used in the treatment of type 2 diabetes. Tirzepatide is the first drug in a class of agents known as dual glucagon-like peptide-1 (GLP-1) …

Tirzepatide (as Mounjaro) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. [9][13] Tirzepatide (as Zepbound) is indicated, alongside …

Dec 27, 2024 · Find patient medical information for Zepbound (tirzepatide) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

May 11, 2025 · Tirzepatide and semaglutide are highly effective medications for obesity management. The efficacy and safety of tirzepatide as compared with semaglutide in adults …